The main purpose of the two open, non-comparative PMS studies reported here was to extend the knowledge base of the efficacy and tolerability of once-daily valsartan (trial 1) and the fixed ...

28,29 In view of the disproportionate elevation of central aortic pressures in patients with systolic hypertension and stiffened arteries, we were interested to determine whether the novel angiotensin ...

High blood pressure, or hypertension, is a widespread health condition that affects people of all ages worldwide. If left ...

Hypertension, also known as high blood pressure, is the most common cardiovascular risk factor. It describes a condition ...

AT-II-receptor antagonists include losartan, valsartan, irbesartan ... warfarin, and hydrochlorothiazide. All available AT-II-receptor antagonists seem to be equally effective in reducing both ...

The 15 medicines included in the initiative include three branded medicines: valsartan for hypertension ... bisoprolol, hydrochlorothiazide, furosemide and ramipril), high cholesterol (simvastatin ...